Previous Close | 0.2100 |
Open | 0.1950 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.1900 - 0.1950 |
52 Week Range | 0.1700 - 0.3430 |
Volume | |
Avg. Volume | 12,336 |
Market Cap | 14.378M |
Beta (5Y Monthly) | 0.64 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0300 |
Earnings Date | May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Aurora Spine ( CVE:ASG ) Full Year 2023 Results Key Financial Results Revenue: US$14.5m (down 2.4% from FY 2022). Net...
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for fiscal 2023 ended December 31, 2023. The company experienced strong, successive, quarter over quarter revenue growth, while overcoming early year o
CARLSBAD, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants announced today that it has completed the second full year of implantation of the world’s first patient-bone-density matched interbody device, the cervical interbody DEXA-C. Trent Northcutt, CEO and President at Aurora Spine said, "It's a significant milestone for Aurora to celebrate the second anniversary of the